Correlation of hTERT Expression with Cervical Cytological Abnormalities and Human Papillomavirus Infection
References
- 1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.1, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http://globocan.iarc.fr, last accessed on 23/01/2017.
- 2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013; 49(6):1374-403.10.1016/j.ejca.2012.12.027
- 3. Richart RM. Cervical intraepithelial neoplasia. Pathol Annu.1973; 8:301-28.
- 4. Lorincz AT, Reid R, Jensen AB, et al. Human papillomavirus infection of the cervix; Relative risk associations of 15 common anogenital types. Obstet Gynecol. 1992;39(2):152.10.1016/0020-7292(92)90921-5
- 5. Zuna RE, Wang SS, Schiffman M, et al. Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion. Cancer. 2006; 108(5):288-97. DOI: 10.1002/cncr.22168.10.1002/cncr.22168
- 6. Yim EK, Park JS. The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer Res Treat. 2005; 37(6):319-24. DOI: 10.4143/crt.2005.37.6.319.10.4143/crt.2005.37.6.319
- 7. Gewin L, Galloway DA. E box-dependent activation of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc. J. Virol 2001. 75:7198-201. DOI: 10.1128/JVI.75.15.7198-7201.2001.10.1128/JVI.75.15.7198-7201.2001
- 8. Oh, ST, Kyo S, Laimins LA. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites. J Virol. 2001; 75:5559-66. DOI: 10.1128/JVI.75.12.5559-5566.2001.10.1128/JVI.75.12.5559-5566.2001
- 9. Veldman T, Horikawa I, Barrett JC, et al. Transcriptional activation of the telomerase hTERT gene by human papillomavirus type 16 E6 oncoprotein. J Virol. 2001. 75:4467-72. DOI: 10.1128/JVI.75.9.4467-4472.2001.10.1128/JVI.75.9.4467-4472.2001
- 10. Chen CH, Chen RJ. Prevalence of telomerase activity in human cancer. J Formos Med Assoc. 2011; 110(5):275-89. DOI:10.1016/S0929-6646(11)60043-0.10.1016/S0929-6646(11)60043-0
- 11. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science. 1995; 269:1236-41. DOI: 10.1126/science.7544491.10.1126/.7544491
- 12. Kilian A, Bowtell DD, Abud HE, et al. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet. 1997; 6:2011-9.10.1093/hmg/6.12.20119328464
- 13. Gardano L, Holland L, Oulton R, et al. Native gel electrophoresis of human telomerase distinguishes active complexes with or without dyskerin. Nucleic Acids Res. 2012; 40(5):e36. DOI:10.1093/nar/gkr1243.10.1093/nar/gkr1243
- 14. Collins K. Structure and function of telomerase. Curr Opin Cell Biol. 1996; 8:374–80. DOI: 10.1016/S0955-0674(96)80013-5.10.1016/S0955-0674(96)80013-5
- 15. Hiyama E, Tatsumoto N, Kodama T, et al. Telomerase activity in human intestine. Int J Oncol. 1996; 9(3): 453-8. DOI: 10.3892/ijo.9.3.453.10.3892/ijo.9.3.453
- 16. Zhang F, Huber O, Ménard L, et al. Pontin and reptin, two related ATPases with multiple roles in cancer. Cancer Res. 2008; 68(17):6873-6. DOI: 10.1158/0008-5472.CAN-08-0547.10.1158/0008-5472.CAN-08-0547
- 17. Zhang F, Cheng D, Wang S, Zhu J. Human Specific Regulation of the Telomerase Reverse Transcriptase Gene. Genes (Basel). 2016; 7(7). pii: E30. DOI: 10.3390/genes7070030.10.3390/genes7070030
- 18. Yoshida K, Sugino T, Goodison S, et al. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications. Br J Cancer. 1997; (75) 548-553. DOI:10.1038/bjc.1997.96.10.1038/bjc.1997.96
- 19. Myung SJ, Yang SK, Chang HS, et al. Clinical usefulness of telomerase for the detection of colon cancer in ulcerative colitis patients. J Gastroenterol Hepatol. 2005; (20)1578-1583. DOI: 10.1111/j.1440-1746.2005.03877.x.10.1111/j.1440-1746.2005.03877.x
- 20. Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell. 1997; 90(4):785-95. DOI: http://dx.doi.org/10.1016/S00928674(00)80538-3.10.1016/S00928674(00)80538-3
- 21. Frost M, Bobak JB, Gianani R, et al. Localization of telomerase hTERT protein and hTR in benign mucosa, dysplasia, and squamous cell carcinoma of the cervix. Am J Clin Pathol. 2000; 114(5): 726-34. DOI:10.1309/XWFE-ARMN-HG2D-AJYV.10.1309/XWFE-ARMN-HG2D-AJYV11068546
- 22. Yokoyama Y, Takahashi Y, Shinohara A, et al. Telomerase activity in the female reproductive tract and neoplasms. Gynecol Oncol. 1998; 68:145-9 DOI:10.1006/gyno.1997.4921.10.1006/gyno.1997.49219514809
- 23. Kyo S, Takakura M, Kohama T, et al. Telomerase activity in human endometrium Cancer Res. 1997; 57:610-4.
- 24. Yokoyama Y, Takahashi Y, Morishita S, et al. Telomerase activity in the human endometrium throughout the menstrual cycle. Mol Hum Reprod. 1998; 4:173-7. DOI: 10.1093/molehr/4.2.173.10.1093/molehr/4.2.1739542976
- 25. Gorham H, Yoshida K, Sugino T, et al. Telomerase activity in human gynecological malignancies. J Clin Pathol. 1997; 50:501-4. DOI: 10.1136/jcp.50.6.501.10.1136/jcp.50.6.5014999879378818
- 26. Brien TP, Kallakury BV, Lowry CV, et al. Telomerase activity in benign endometrium and endometrial carcinoma. Cancer Res. 1997; 57: 2760-64.
- 27. Nobre RJ, de Almeida LP, Martins TC. Complete genotyping of mucosal human papillomavirus using a restriction fragment length polymorphism analysis and an original typing algorithm. J Clin Virol. 2008; 42(1):13-21. DOI: 10.1016/j.jcv.2007.11.021.10.1016/j.jcv.2007.11.02118304866
- 28. Saleh S, Lam AK, Ho YH. Real-time PCR quantification of human telomerase reverse transcriptase (hTERT) in colorectal cancer. Pathology. 2008; 40(1):25-30. DOI: 10.1080/00313020701716425.10.1080/0031302070171642518038311
- 29. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001; 25(4):402-8. DOI: 10.1006/meth.2001.1262.10.1006/meth.2001.126211846609
- 30. Branca M, Giorgi C, Ciotti M, et al. Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer. Diagn Cytopathol. 2006; 34(11):739-48. DOI: 10.1002/dc.20554.10.1002/dc.2055417041957
- 31. Hsu CG, Wang PH, Ko JL, et al. Concurrent high expression of human telomerase reverse transcriptase and human non metastatic clone 23 in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of uterine cervix. Int J Gynecol Cancer. 2007;17(4):851-7. DOI:10.1111/j.1525-1438.2007.00894.x.10.1111/j.1525-1438.2007.00894.x17359290
- 32. Wang HY, Park S, Kim S, et al. Use of hTERT and HPV E6/E7 mRNA RT-qPCR TaqMan assays in combination for diagnosing high-grade cervical lesions and malignant tumors. Am J Clin Pathol. 2015; 143(3):344-51. DOI:10.1309/AJCPF2XGZ2XIQYQX.10.1309/AJCPF2XGZ2XIQYQX25696792
- 33. Saretzki G, Fischer H, Kaufmann IG, et al. Telomerase activity in cervical smears. Anal Cell Pathol. 2001; 23(1):39-43. DOI: 10.1155/2001/630972.10.1155/2001/630972461882211790858
- 34. Reesink-Peters N, Helder MN, Wisman GB, et al. Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasia. J Clin Pathol. 2003; 56(1):31-5. DOI:10.1136/jcp.56.1.31.10.1136/jcp.56.1.31176985512499429
- 35. Nagai N, Oshita T, Murakami J, et al. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions. Oncol Rep. 1999; 6(2):325-8. DOI:10.3892/or.6.2.325.10.3892/or.6.2.325
- 36. Reddy VG, Khanna N, Jain SK, et al. Telomerase-A molecular marker for cervical cancer screening. Int J Gynecol Cancer. 2001; 11(2):100-6. DOI: 10.1046/j.1525-1438.2001.00095.x.10.1046/j.1525-1438.2001.00095.x
- 37. Castro-Duque AF, Loango-Chamorro N, Ruiz-Hoyos BM, et al. Telomerase activity associated with progression of cervical lesions in a group of Colombian patients. Rev Bras Ginecol Obstet. 2015; 37(12):559-64. DOI: 10.1590/SO100-720320150005462.10.1590/SO100-720320150005462
- 38. Kyo S, Takakura M, Tanaka M, et al. Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions. Int J Cancer. 1998; 79(1):66-70. DOI: 10.1002/(SICI)1097-0215(19980220)79:1<66::AID-IJC13>3.0.CO;2-F.10.1002/(SICI)1097-0215(19980220)79:1<66::AID-IJC13>3.0.CO;2-
- 39. Takakura M, Kyo S, Kanaya T, et al. Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res. 1998; 58(7):1558-61.
- 40. Ault KA, Allen HK, Phillips SL, et al. Telomerase activity as a potential diagnostic marker for triage of abnormal Pap smears. J Low Genit Tract Dis. 2005; 9(2):93. DOI: 10.1097/00128360-200504000-00005.10.1097/00128360-200504000-00005
- 41. Kailash U, Soundararajan CC, Lakshmy R, et al. Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer. Br J Cancer. 2006;95(9):1250-7. DOI:10.1038/sj.bjc.6603375.10.1038/sj.bjc.6603375
- 42. Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev. 2002;66(3):407-25. DOI: 10.1128/MMBR.66.3.407-425.2002.10.1128/MMBR.66.3.407-425.2002
- 43. Cao Y, Bryan TM, Reddel RR. Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Sci. 2008; 99(6):1092-9. DOI: 10.1111/j.1349-7006.2008.00815.x.10.1111/j.1349-7006.2008.00815.x
- 44. Klingelhutz AJ, Foster SA, McDougall JK. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature. 1996; 380(6569):79-82. DOI:10.1038/380079a0.10.1038/380079a0
- 45. Huang PS, Patrick DR, Edwards G, et al. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein. Mol Cell Biol. 1993; 13(2):953-60. DOI: 10.1128/MCB.13.2.953.10.1128/MCB.13.2.953
- 46. Oh ST, Kyo S, Laimins LA. Telomerase activation by human papillomavirus type 16 E6 protein: induction of human telomerase reverse transcriptase expression through Myc and GC-rich Sp1 binding sites. J Virol. 2001; 75(12):5559-66. DOI:10.1128/JVI.75.12.5559-5566.2001.10.1128/JVI.75.12.5559-5566.200111426811356963
- 47. Cullen AP, Reid RI, Campion MI, et al. Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. J Virol. 1991;65(2):606-12.10.1128/jvi.65.2.606-612.1991
- 48. Doorbar J, Quint W, Banks L, et al. The biology and life-cycle of human papillomaviruses. Vaccine. 2012; 30:F55-70. DOI: 10.1016/j.vaccine.2012.06.083.10.1016/j.vaccine.2012.06.08323199966
- 49. Wang SZ, Sun JH, Zhang W, et al. Telomerase activity in cervical intraepithelial neoplasia. Chin Med J (Engl). 2004; 117(2):202-6.
- 50. Snijders PJ, van Duin M, Walboomers JM, et al. Telomerase activity exclusively in cervical carcinomas and a subset of cervical intraepithelial neoplasia grade III lesions: strong association with elevated messenger RNA levels of its catalytic subunit and high-risk human papillomavirus DNA. Cancer Res. 1998; 58(17):3812-8.
Language: English
Page range: 143 - 151
Published on: Apr 16, 2018
Published by: Macedonian Academy of Sciences and Arts
In partnership with: Paradigm Publishing Services
Publication frequency: 3 issues per year
Related subjects:
© 2018 Vjosa A. Zejnullahu, Valon A. Zejnullahu, Slavica Josifovska, Nikola Vukovik, Kiril Pakovski, Sasho Panov, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.